|
 |
|
|
| |
|
|
| |
|
|
| |
China approves Calypte's oral HIV test
 |
|
| US healthcare company Calypte Biomedical has received registration and marketing approval for Aware HIV-1/2 OMT (oral fluid) rapid test from the SFDA of China
|
|
 |
|
|
| |
|
|
| |
| CV, Astellas get FDA approval for Lexiscan injection
|
|
| CV Therapeutics and the US arm of Japanese firm Astellas Pharma have received approval from the US FDA for Lexiscan injection for use as a pharmacologic stress agent in radionuclide myocardial perfusion imaging |
|
|
|
|
| |
|
|
| |
| Abraxis to market Abraxane in Korea
|
|
| The Korean FDA (KFDA) has granted marketing approval for US-based Abraxis BioScience's Abraxane to treat breast cancer after failure of standard chemotherapy |
|
|
|
|
| |
|
|
| |
|
|
| More |
